Clik here to view.
EyeBio Announces First Asset in Innovative Pipeline of Retinal Disease...
LONDON & NEW YORK Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to patients with...
View ArticleClik here to view.
HPO, in Collaboration with Eastman, Announces Upcoming Launch of High Energy...
CHARLOTTE, N.C. Eastman and High Performance Optics, Inc. (HPO) announced today that a selective High Energy Visible Light (HEVL) filtering window film for the transportation industry will be...
View ArticleClik here to view.
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received...
View ArticleClik here to view.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal...
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at...
View ArticleClik here to view.
OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been successfully dosed in a Phase 1 clinical...
View ArticleClik here to view.
Nova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance...
FREMONT, Calif. Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today...
View ArticleClik here to view.
Novaliq 宣布 CyclASol 0.1%（环孢霉素眼用溶液）第二个关键 3 期试验数据已在《JAMA 眼科学》上发表
德国海德堡市和美国麻省剑桥市 (美国商业资讯)–Novaliq 是一家生物制药公司，专注于基于独特的 EyeSol® 无水技术的一流和最佳眼科治疗方案。该公司今天宣布 CyclASol® 的第二个关键 3 期试验结果，即 ESSENCE-2 已经在美国医学会杂志《JAMA 眼科学》上发表。 CyclASol®...
View ArticleClik here to view.
Volvo EX90 Electric SUV Will Feature Seoul Semiconductor’s SunLike LED Lighting
ANSAN, South Korea Seoul Semiconductor Co., Ltd. (KOSDAQ:046890), a global optical semiconductor company, has announced that the new Volvo EX90 Electric SUV will feature its SunLike LED lights. This...
View ArticleClik here to view.
沃尔沃EX90电动SUV将采用首尔半导体的SunLike LED照明
韩国安山 (美国商业资讯)–首尔半导体株式会社(Seoul Semiconductor Co., Ltd., KOSDAQ:046890)是一家全球光学半导体公司。公司宣布，新款沃尔沃EX90电动SUV将配备其SunLike LED灯。这是太阳光谱SunLike技术在量产车中的首次应用。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ボルボの電動SUV「EX90」にソウル半導体のSunLike LED照明を搭載
韓国、安山市 （ビジネスワイヤ） — 光半導体の世界的企業であるソウル半導体（KOSDAQ:046890)は、ボルボの新型電動SUV「EX90」にSunLike LEDライトが搭載されるようになることを発表しました。太陽スペクトルを持つSunLike技術が量産車に適用されるのは今回が初となります。...
View ArticleClik here to view.
Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented...
FORT LEE, N.J. Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today announced the...
View ArticleClik here to view.
NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and...
EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces that China Pioneer Pharma Holdings, Limited (HK Stock Code:1345), a leading Chinese importer and marketer of branded...
View ArticleClik here to view.
Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in...
DUBLIN Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment of adults with...
View ArticleClik here to view.
Novaliq Announces Presentation of New Scientific Data on CyclASol® 0.1%...
HEIDELBERG, Germany & CAMBRIDGE, Mass. Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today...
View ArticleClik here to view.
制药公司 Novaliq 宣布在美国白内障和屈光手术学会年会上公布 CyclASol® 0.1%（环孢素滴眼液）的最新科学数据
德国海德堡和马萨诸塞州剑桥 (美国商业资讯)– 生物制药公司 Novaliq 今天宣布，将在美国白内障和屈光手术学会 (ASCRS) 年会上公布有关试验性新药疗法 CyclASol® 0.1%（环孢素滴眼液）的最新数据。Novaliq 公司专注于借助独家 EyeSol® 无水技术、研发业内首创和一流的眼科治疗药物。ASCRS 年会将于 2023 年 5 月 5 日至 8 日在圣地亚哥举行。...
View ArticleClik here to view.
iTrack™ Canaloplasty to be Featured in Numerous Scientific Presentations at...
FREMONT, Calif. Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce that its proprietary iTrack™...
View ArticleClik here to view.
Drug Farm Raises $27M USD Financing for Advancement of First-In-Class...
GUILFORD, Conn. & SHANGHAI Drug Farm, a private biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies, has raised the first...
View ArticleClik here to view.
Seoul Semiconductor在2023年显示周上推出面向未来显示器的第二代LED技术
韩国安山 (美国商业资讯)– Seoul Semiconductor Co., Ltd. (KOSDAQ:046890)是一家全球光学半导体公司。该公司将参加国际信息显示学会(SID)于5月23日至25日举办的2023年显示周(Display Week 2023)，展示面向未来显示器的第二代LED技术，包括基于WICOP...
View ArticleClik here to view.
ソウル半導体、「ディスプレイ・ウィーク 2023で未来のディスプレイ向け第2世代LED技術を初公開
韓国安山市 （ビジネスワイヤ） — ソウル半導体（KOSDAQ:046890）は、5月23～25日に開催されるSociety for Information...
View ArticleClik here to view.
6月6日是“全国爱眼日”，窪田制药将在日本的Kubota Glass Store举行特别展览活动
东京都港区 (美国商业资讯)–窪田制药控股有限公司（总部：东京都港区；以下简称“公司”）欣然宣布，将在日本的Kubota Glass Store限时举办特别展览活动。 Kubota Glass利用AR技术重现了一个户外环境。活动将在中国的6月6日“全国爱眼日”和日本的6月10日“儿童爱眼日”期间举行。从今年开始，日本将6月10日指定为“儿童爱眼日”。 在日本和中国宣传爱眼日...
View Article